ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences has announced an analyst and investor conference call scheduled for Wednesday, May 20, 2026 at 4:30 PM IST. The call is for Q4 and FY2026 earnings discussion. This follows a prior board meeting intimation from May 15, 2026, where directors were to consider and approve the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. The announcement complies with SEBI (LODR) Regulations, 2015, specifically Regulation 30. Contact details for investor relations are provided with a Zoom webinar registration link.
This is a routine disclosure informing the market about an upcoming earnings call. The scheduled call indicates the company is on track to release Q4 and FY2026 results soon, allowing analysts and investors to prepare questions and participate in discussions about performance.